Carbapenem Hydrolysing Oxacillinase in Acinetobacter baumannii
Journal of Progressive Medical Sciences · 28.02.2026 · 1 (4)
DOI: 10.63939/0h70qx09 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Progressive Medical Sciences, online erschienen am 28.02.2026. Verfasst von Hela Chihi und 3 weiteren Autor:innen.
Abstract (Originalsprache)
The global rise in carbapenem resistance in Acinetobacter baumannii is alarming, as it severely restricts available therapeutic options. Among the resistance mechanisms identified in this species, carbapenem-hydrolyzing class D β-lactamases (CHDLs) represent the most prevalent β-lactamases and are largely specific to A. baumannii. This review focuses on the different clusters of oxacillinases that have been reported in Acinetobacter baumannii worldwide. Keywords: Acinetobacter baumannii, CHDLs, carbapenem-hydrolyzing, β-lactamases.
Zitieren
APA
Chihi, H., Bourouis, A., Naghmouchi, K., & Ben-Mehrez, K. (2026). Carbapenem Hydrolysing Oxacillinase in Acinetobacter baumannii. Journal of Progressive Medical Sciences, 1(4). https://doi.org/10.63939/0h70qx09
Vancouver
Chihi H, Bourouis A, Naghmouchi K, Ben-Mehrez K. Carbapenem Hydrolysing Oxacillinase in Acinetobacter baumannii. Journal of Progressive Medical Sciences. 2026;1(4). doi:10.63939/0h70qx09
BibTeX
@article{Chihi2026,
author = {Chihi, Hela and Bourouis, Amel and Naghmouchi, Karim and Ben-Mehrez, Kamel},
title = {Carbapenem Hydrolysing Oxacillinase in Acinetobacter baumannii},
journal = {Journal of Progressive Medical Sciences},
year = {2026},
volume = {1},
number = {4},
doi = {10.63939/0h70qx09}
}
EUVIMED